3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Oropharyngeal Neoplasms
11
Lung Neoplasms
8
Laryngeal Neoplasms
8
Carcinoma
8
Mouth Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Hypopharyngeal Neoplasms
6
Nasopharyngeal Carcinoma
5
Mesothelioma, Malignant
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Lymphoid Interstitial Pneumonia
3
Gallbladder Neoplasms
3
Triple Negative Breast Neoplasms
2
Salivary Gland Neoplasms
2
Paranasal Sinus Neoplasms
2
Ovarian Neoplasms
2
Medulloblastoma
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Interventions
Etoposide
31
Carboplatin
30
atezolizumab
17
durvalumab
16
Cisplatin
14
Topotecan
11
PM 01183
11
Specimen Handling
9
pembrolizumab
8
Magnetic Resonance Spectroscopy
7
olaparib
5
Radiotherapy
5
berzosertib
4
anlotinib
4
Paclitaxel
4
Nivolumab
4
Irinotecan
4
Drug Therapy
4
tremelimumab
3
toripalimab
3
tislelizumab
3
Temozolomide
3
Radiosurgery
3
Injections
3
Docetaxel
3
Biopsy
3
Bevacizumab
3
AMG 757
3
sacituzumab govitecan
2
monalizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
90 days
×
Clear all
No trials found.